News : 2013 : October

{image-title}

International Collaboration Finds 11 New Alzheimer’s Genes to Target for Drug Discovery

Study yields fresh look at role of immune system in Alzheimer’s

Read more »

The Miller School’s IGAP team includes, from left, John R. Gilbert, Ph.D., Gary Beecham, Ph.D., Eden R. Martin, Ph.D., Brian Kunkle, Ph.D., Margaret A. Pericak-Vance, Ph.D., and Kara Hamilton-Nelson. Not pictured is  Amanda Meyers, Ph.D.

International Collaboration Finds 11 New Alzheimer’s Genes to Target for Drug Discovery

University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer’s disease genetics collaboration to date, which identified 11 new regions of the genome that contribute to late-onset Alzheimer’s disease, doubling the number of potential genetics-based therapeutic targets to investigate.

Read more »

{image-title}

Genome-wide Study Brings MS Landscape Into Sharper Focus

In an interview with the Multiple Sclerosis Discovery Forum, Jacob McCauley, Ph.D., explained how the IMSGC team used ImmunoChip to identify 48 new genetic variations associated with MS

Read more »

Zane Zeier, Ph.D, Claes Wahlestedt, M.D., Ph.D., and Michael Benatar, M.D., Ph.D.

Defense Department Awards ALS Drug Development Grant to Miller School Researchers

A new drug development grant from the U.S. Department of Defense will allow researchers at the University of Miami Miller School of Medicine to study potential treatments for amyotrophic lateral sclerosis (ALS), a neurological degenerative condition commonly called Lou Gehrig’s disease.

Read more »